Nomura Holdings Inc Incyte Corp Call Options Transaction History

Nomura Holdings Inc

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$56.55 - $66.59 $797,355 - $938,919	14,100 New	14,100 $803,000
Q1 2023 May 15, 2023	BUY	$70.23 - $86.01 $2.56 Million - $3.14 Million	36,500 New	36,500 $2.64 Million
Q1 2020 May 14, 2020	SELL	$63.18 - $85.97 $1.9 Million - $2.58 Million	-30,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $1.46 Million - $1.91 Million	20,000 Added 200.0%	30,000 $2.62 Million
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $735,200 - $887,000	10,000 New	10,000 $855,000

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.